ZA975749B - Steroid bisphosphonates - Google Patents

Steroid bisphosphonates

Info

Publication number
ZA975749B
ZA975749B ZA975749A ZA975749A ZA975749B ZA 975749 B ZA975749 B ZA 975749B ZA 975749 A ZA975749 A ZA 975749A ZA 975749 A ZA975749 A ZA 975749A ZA 975749 B ZA975749 B ZA 975749B
Authority
ZA
South Africa
Prior art keywords
bisphosphonates
steroid
steroid bisphosphonates
Prior art date
Application number
ZA975749A
Other languages
English (en)
Inventor
James Anthony Gallagher
Jonathan Paul Granville Moore
Wayne Barry Bowler
Philip Charles Bulman Page
Original Assignee
Univ Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liverpool filed Critical Univ Liverpool
Publication of ZA975749B publication Critical patent/ZA975749B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/548Phosphates or phosphonates, e.g. bone-seeking

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA975749A 1996-06-28 1997-06-27 Steroid bisphosphonates ZA975749B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9613722.9A GB9613722D0 (en) 1996-06-28 1996-06-28 Chemical compounds

Publications (1)

Publication Number Publication Date
ZA975749B true ZA975749B (en) 1998-07-27

Family

ID=10796129

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA975749A ZA975749B (en) 1996-06-28 1997-06-27 Steroid bisphosphonates

Country Status (23)

Country Link
US (1) US6140518A (xx)
EP (1) EP0912598A1 (xx)
JP (1) JP2000513372A (xx)
KR (1) KR20000022262A (xx)
CN (1) CN1226253A (xx)
AP (1) AP9801431A0 (xx)
AU (1) AU3350697A (xx)
BG (1) BG103123A (xx)
BR (1) BR9710074A (xx)
CA (1) CA2259309A1 (xx)
CZ (1) CZ432398A3 (xx)
EE (1) EE9800454A (xx)
GB (1) GB9613722D0 (xx)
HU (1) HUP9902880A3 (xx)
IL (1) IL127781A0 (xx)
IS (1) IS4931A (xx)
NO (1) NO986112L (xx)
PL (1) PL330781A1 (xx)
SK (1) SK175198A3 (xx)
TR (1) TR199900490T2 (xx)
WO (1) WO1998000438A1 (xx)
YU (1) YU59898A (xx)
ZA (1) ZA975749B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8586781B2 (en) 1998-04-02 2013-11-19 Mbc Pharma, Inc. Bone targeted therapeutics and methods of making and using the same
US6896871B2 (en) 1998-04-02 2005-05-24 Mbc Research, Inc. Biphosphonate conjugates and methods of making and using the same
US7598246B2 (en) * 1998-04-02 2009-10-06 Mbc Pharma, Inc. Bisphosphonate conjugates and methods of making and using the same
ATE451382T1 (de) 1999-01-20 2009-12-15 Takara Bio Inc 4-substituierte-3,6-anhydro-galaktosederivate und ihre pharmazeutische verwendung
AU781068B2 (en) * 1999-08-19 2005-05-05 Sydney Children's Hospitals Network (Randwick and Westmead) (incorporating The Royal Alexandra Hospital for Children), The Drug for treating fractures
AUPQ232599A0 (en) * 1999-08-19 1999-09-09 Royal Alexandra Hospital For Children, The Drug for treating fractures
US6436386B1 (en) 2000-11-14 2002-08-20 Shearwater Corporation Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
US7829074B2 (en) 2001-10-18 2010-11-09 Nektar Therapeutics Hydroxypatite-targeting poly(ethylene glycol) and related polymers
EP1383510B1 (en) * 2001-04-10 2012-10-17 MBC Pharma, Inc. Bisphosphonate conjugates and methods of making and using the same
EA200401565A1 (ru) * 2002-05-24 2005-04-28 Неофарм, Инк. Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
JP2006518701A (ja) * 2002-05-24 2006-08-17 ネオファーム、インコーポレイティッド カルジオリピン組成物、その製造方法及び使用
US20050277611A1 (en) * 2002-10-16 2005-12-15 Neopharm, Inc. Cationic cardiolipin analoges and its use thereof
US20060078560A1 (en) * 2003-06-23 2006-04-13 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
FI20070244A0 (fi) 2007-03-23 2007-03-23 Metso Paper Inc Tela
CA2702945C (en) 2007-10-23 2016-08-23 Nektar Therapeutics Al, Corporation Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom
CA2843885C (en) 2011-08-01 2020-03-10 Mbc Pharma, Inc. Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
CN103945869A (zh) * 2011-08-31 2014-07-23 马林克罗特有限公司 使用h-膦酸酯-烯/-炔的氢膦酸酯化反应进行的靶向纳米颗粒的远程组装
US10660884B2 (en) 2015-11-02 2020-05-26 University Of Rochester Phosphonate-chloroquine conjugates and methods using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4029499A1 (de) * 1990-09-18 1992-03-19 Boehringer Mannheim Gmbh Neue 17-(beta)-oestradiolderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
EP0496520A1 (en) * 1991-01-22 1992-07-29 Merck & Co. Inc. Novel bone acting agents
FR2683527A1 (fr) * 1991-11-12 1993-05-14 Bretagne Occidentale Universit Prodrogues gem-bisphosphonates de sterouides derives de la cortisone.
JP3141053B2 (ja) * 1991-12-26 2001-03-05 アベンティス ファーマ株式会社 ビスホスホン酸誘導体
JP2746041B2 (ja) * 1992-02-14 1998-04-28 三菱化学株式会社 新規なステロイド誘導体

Also Published As

Publication number Publication date
AP9801431A0 (en) 1998-12-31
CZ432398A3 (cs) 1999-05-12
YU59898A (en) 1999-11-22
SK175198A3 (en) 1999-06-11
WO1998000438A1 (en) 1998-01-08
NO986112D0 (no) 1998-12-23
BG103123A (en) 1999-10-29
AU3350697A (en) 1998-01-21
IS4931A (is) 1998-12-22
KR20000022262A (ko) 2000-04-25
HUP9902880A3 (en) 2001-09-28
CN1226253A (zh) 1999-08-18
IL127781A0 (en) 1999-10-28
BR9710074A (pt) 2000-01-18
PL330781A1 (en) 1999-06-07
HUP9902880A2 (hu) 2000-03-28
GB9613722D0 (en) 1996-08-28
NO986112L (no) 1999-02-23
CA2259309A1 (en) 1998-01-08
US6140518A (en) 2000-10-31
EE9800454A (et) 1999-06-15
JP2000513372A (ja) 2000-10-10
TR199900490T2 (xx) 1999-05-21
EP0912598A1 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
PL333376A1 (en) Connection cubicle
DE59700372D1 (en) Blockcopolymere
IL127781A0 (en) Steroid bisphosphonates
GB2311033B (en) Combination part
PL332732A1 (en) Combination toy-candy
DE59703023D1 (en) Cyclopeptidderivate
DE59702027D1 (en) Bragg-modulator
GB9608180D0 (en) Phosphate analogues
GB2318268B (en) Attachment means
AU131132S (en) Handleset
GB9619768D0 (en) Phosphorylation
AU131198S (en) Handleset
DE59610178D1 (en) Rotationspumpe
AU3389797A (en) Phosphocholinate cardenolides
AU131131S (en) Handleset
AU131199S (en) Handleset
GB9620014D0 (en) Phosphorylation
CA79582S (en) Jerkin
AU1593P (en) Songlines Telopea speciosissima
GB9602855D0 (en) 17-Alkyl-7-substituted-4-aza steroid derivatives
GB9610660D0 (en) Safetyt aid
GB9602765D0 (en) Publicans pipecleaning aid
AU134545S (en) Coving
GB9601968D0 (en) Windshelter for sun-bathing
PL105793U1 (en) Integrated euro-currency system